Literature DB >> 23179651

Imaging characteristics of cerebrovascular arteriopathy and stroke in Hutchinson-Gilford progeria syndrome.

V M Silvera1, L B Gordon, D B Orbach, S E Campbell, J T Machan, N J Ullrich.   

Abstract

BACKGROUND AND
PURPOSE: HGPS is a rare disorder of segmental aging, with early morbidity from cardiovascular and cerebrovascular disease. The goal of this study was to identify the neurovascular features, infarct type, topography, and natural history of stroke in the only neurovascular imaging cohort study of HGPS.
MATERIALS AND METHODS: We studied 25 children with confirmed diagnoses of HGPS and neuroimaging studies available for review. Relevant clinical information was abstracted from medical records.
RESULTS: We identified features suggestive of a vasculopathy unique to HGPS, including distinctive intracranial steno-occlusive arterial lesions, basal cistern collateral vessels, and slow compensatory collateral flow over the cerebral convexities. The arterial pathology in the neck consisted of distal vertebral artery stenosis with prominent collateral vessel formation as well as stenosis and calcification of both the cervical internal and common carotid arteries. Radiographic evidence of infarction was found in 60% of patients, of which half were likely clinically silent. Both large- and small-vessel disease was observed, characterized by arterial territorial, white matter, lacunar, and watershed infarcts.
CONCLUSIONS: We report a unique intracranial and superior cervical arteriopathy in HGPS distinct from other vasculopathies of childhood, such as Moyamoya, and cerebrovascular disease of aging, including atherosclerosis. Arterial features of the mid and lower neck are less distinctive. For the first time, we identified early and clinically silent strokes as a prevalent disease characteristic in HGPS. Longitudinal analysis of stroke incidence and vasculopathy may provide an outcome measure for future treatment interventions for children with HGPS.

Entities:  

Mesh:

Year:  2012        PMID: 23179651      PMCID: PMC7964639          DOI: 10.3174/ajnr.A3341

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  27 in total

1.  Collateralization of vertebral arteries.

Authors:  P Garnier; A C Januel; S Demasles; D Michel
Journal:  Neurology       Date:  2003-02-25       Impact factor: 9.910

2.  Human longevity and common variations in the LMNA gene: a meta-analysis.

Authors:  Karen N Conneely; Brian C Capell; Michael R Erdos; Paola Sebastiani; Nadia Solovieff; Amy J Swift; Clinton T Baldwin; Temuri Budagov; Nir Barzilai; Gil Atzmon; Annibale A Puca; Thomas T Perls; Bard J Geesaman; Michael Boehnke; Francis S Collins
Journal:  Aging Cell       Date:  2012-03-27       Impact factor: 9.304

Review 3.  Hutchinson-Gilford progeria syndrome: review of the phenotype.

Authors:  Raoul C M Hennekam
Journal:  Am J Med Genet A       Date:  2006-12-01       Impact factor: 2.802

4.  MRA detection of vascular occlusion in a child with progeria.

Authors:  A S Smith; M Wiznitzer; B A Karaman; S J Horwitz; C F Lanzieri
Journal:  AJNR Am J Neuroradiol       Date:  1993 Mar-Apr       Impact factor: 3.825

5.  Cardiovascular abnormalities in progeria. Case report and review of the literature.

Authors:  P B Baker; N Baba; C P Boesel
Journal:  Arch Pathol Lab Med       Date:  1981-07       Impact factor: 5.534

Review 6.  Pathogenesis of leukoaraiosis: a review.

Authors:  L Pantoni; J H Garcia
Journal:  Stroke       Date:  1997-03       Impact factor: 7.914

7.  Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome.

Authors:  Maria Eriksson; W Ted Brown; Leslie B Gordon; Michael W Glynn; Joel Singer; Laura Scott; Michael R Erdos; Christiane M Robbins; Tracy Y Moses; Peter Berglund; Amalia Dutra; Evgenia Pak; Sandra Durkin; Antonei B Csoka; Michael Boehnke; Thomas W Glover; Francis S Collins
Journal:  Nature       Date:  2003-04-25       Impact factor: 49.962

Review 8.  Moyamoya disease and moyamoya syndrome.

Authors:  R Michael Scott; Edward R Smith
Journal:  N Engl J Med       Date:  2009-03-19       Impact factor: 91.245

Review 9.  New approaches to progeria.

Authors:  Mark W Kieran; Leslie Gordon; Monica Kleinman
Journal:  Pediatrics       Date:  2007-10       Impact factor: 7.124

10.  Pediatric stroke: a review.

Authors:  Daniel S Tsze; Jonathan H Valente
Journal:  Emerg Med Int       Date:  2011-12-27       Impact factor: 1.112

View more
  12 in total

Review 1.  Hutchinson-Gilford Progeria Syndrome: A Premature Aging Disease.

Authors:  Muhammad Saad Ahmed; Sana Ikram; Nousheen Bibi; Asif Mir
Journal:  Mol Neurobiol       Date:  2017-06-28       Impact factor: 5.590

2.  The clinical characteristics of Asian patients with classical-type Hutchinson-Gilford progeria syndrome.

Authors:  Nanae Sato-Kawano; Minoru Takemoto; Emiko Okabe; Koutaro Yokote; Muneaki Matsuo; Rika Kosaki; Kenji Ihara
Journal:  J Hum Genet       Date:  2017-09-07       Impact factor: 3.172

3.  [Clinical manifestations and gene mutation analysis of children with noncompaction of the ventricular myocardium: an analysis of 6 cases].

Authors:  Feng-Hua Zhang; Jin-Dou An; Song Feng; Xiao-Jian Zhang; Xiao-Lin Zhao
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2021-01

4.  Neurologic features of Hutchinson-Gilford progeria syndrome after lonafarnib treatment.

Authors:  Nicole J Ullrich; Mark W Kieran; David T Miller; Leslie B Gordon; Yoon-Jae Cho; V Michelle Silvera; Anita Giobbie-Hurder; Donna Neuberg; Monica E Kleinman
Journal:  Neurology       Date:  2013-06-28       Impact factor: 9.910

5.  Phosphorylated Lamin A/C in the Nuclear Interior Binds Active Enhancers Associated with Abnormal Transcription in Progeria.

Authors:  Kohta Ikegami; Stefano Secchia; Omar Almakki; Jason D Lieb; Ivan P Moskowitz
Journal:  Dev Cell       Date:  2020-03-23       Impact factor: 12.270

Review 6.  Hutchinson-Gilford Progeria Syndrome: A premature aging disease caused by LMNA gene mutations.

Authors:  Susana Gonzalo; Ray Kreienkamp; Peter Askjaer
Journal:  Ageing Res Rev       Date:  2016-06-29       Impact factor: 10.895

7.  Survey of plasma proteins in children with progeria pre-therapy and on-therapy with lonafarnib.

Authors:  Leslie B Gordon; Susan E Campbell; Joseph M Massaro; Ralph B D'Agostino; Monica E Kleinman; Mark W Kieran; Marsha A Moses
Journal:  Pediatr Res       Date:  2018-02-28       Impact factor: 3.756

Review 8.  The epidemiology of premature aging and associated comorbidities.

Authors:  Fabio Coppedè
Journal:  Clin Interv Aging       Date:  2013-08-05       Impact factor: 4.458

9.  Generation of a Hutchinson-Gilford progeria syndrome monkey model by base editing.

Authors:  Fang Wang; Weiqi Zhang; Qiaoyan Yang; Yu Kang; Yanling Fan; Jingkuan Wei; Zunpeng Liu; Shaoxing Dai; Hao Li; Zifan Li; Lizhu Xu; Chu Chu; Jing Qu; Chenyang Si; Weizhi Ji; Guang-Hui Liu; Chengzu Long; Yuyu Niu
Journal:  Protein Cell       Date:  2020-07-29       Impact factor: 14.870

10.  An upregulation in the expression of vanilloid transient potential channels 2 enhances hypotonicity-induced cytosolic Ca²⁺ rise in human induced pluripotent stem cell model of Hutchinson-Gillford Progeria.

Authors:  Chun-Yin Lo; Yung-Wui Tjong; Jenny Chung-Yee Ho; Chung-Wah Siu; Sin-Ying Cheung; Nelson L Tang; Shan Yu; Hung-Fat Tse; Xiaoqiang Yao
Journal:  PLoS One       Date:  2014-01-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.